Avec votre autorisation, nous utilisons une analyse limitée et respectueuse de la vie privée pour comprendre les parcours de recherche utiles. Nous n’utilisons ni traceurs publicitaires ni enregistrement de session. Vous pouvez modifier ce choix dans les préférences. Consultez la Politique de confidentialité.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
DOCU — frequently asked questions
Is DocuSign, Inc. overvalued?
In our latest published analysis dated 2026-05-10, DOCU looks meaningfully overvalued. The price recorded at analysis is 47,9 USD versus our fair value of 28,6 USD; the high endpoint is presented separately as potential value of 36,5 USD. That implies roughly 40.3% downside to fair value at that date.
Our latest published report, analyzed 2026-05-10, gives DOCU a fair value of 28,6 USD and a potential value of 36,5 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for DocuSign, Inc.'s archetype; it is a dated research output, not a live price.
Should I buy DOCU now?
Our latest published rating for DOCU, analyzed 2026-05-10, is Sell. DocuSign, Inc. looks meaningfully overvalued at the analysis-date price of 47,9 USD versus fair value of 28,6 USD; potential value is 36,5 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for DOCU?
The dedicated bear-case section in our report analyzed 2026-05-10 documents DocuSign, Inc.'s material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is DOCU's rating?
Our latest published rating for DOCU, analyzed 2026-05-10, is Sell, with a published moat assessment of 6.5/10 (narrow). It reflects our fair value of 28,6 USD, the potential value of 36,5 USD, and the price recorded at analysis (47,9 USD).
Affichage de la source anglaise pendant la traduction
Ce rapport n'a pas encore été traduit. Actualisez dans quelques minutes une fois que la file d'attente de traduction aura rattrapé son retard.
§1 RésuméEN
Réponse en 30 secondesSell
Prix par rapport à la valeur
Cours
$47.90
Juste valeur
$28.60
Valeur potentielle
$36.46
Au
Date de cotation non enregistrée
Pourquoi le scénario peut fonctionner
Bull: Successful expansion of Intelligent Agreement Management (IAM) accelerates revenue back to double-digits, while cost discipline drops the high incremental gross margins straight to the bottom line.
Ce qui changerait notre avis
Severe Pricing Compression: Enterprise customers aggressively negotiate e-signature renewals as bundled alternatives like Adobe become good enough, collapsing gross margins.
DocuSign is a mature software compounder generating exceptional free cash flow and maintaining dominant market share in e-signature. However, heavy stock-based compensation and decelerating top-line growth present valuation headwinds. The base case assumes steady, low-growth cash generation with gradual GAAP margin improvement.
DocuSign is a mature software compounder generating exceptional free cash flow and maintaining dominant market share in e-signature. However, heavy stock-based compensation and decelerating top-line growth present valuation headwinds. The assumes steady, low-growth cash generation with gradual GAAP margin improvement.
Enterprise digitization expands beyond simple signatures into full contract lifecycle management.
Recommandation maison
Sell. Market pricing misprices structural growth deceleration and systemic SBCdilution.
Présentation de l’entreprise
DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company offers AI-powered intelligent agreement management (IAM) platform to optimize the gain intelligence and automation across the entire agreement lifecycle; and provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Document Generation streamlines the process of generating new, custom agreements. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Monitor that uses advanced analytics; Notary which enables notaries public to conduct remote online notarization transactions; and Web Forms. In addition, the company offers Real Estate for eSignature that provides a way for brokers and agents to manage the entire real estate transaction digitally. eSignature and CLM are Federal Risk and Authorization Management Program (FedRAMP), an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and digital self-service purchasing. DocuSign, Inc. was incorporated in 2003 and is headquartered in San Francisco, California.
§2 Cas baissierEN
A rapid acceleration in e-signature commoditization drives intense pricing pressure, collapsing top-line growth to near zero while GAAP margins remain structurally impaired by relentless stock-based compensationdilution.
Commoditization of e-signatures leads to pricing pressure, while persistent high SBC continually dilutes shareholders, offsetting the strong free cash flow generation.
Comment cette thèse peut échouer
Severe Pricing Compression
Medium
Enterprise customers aggressively negotiate e-signature renewals as bundled alternatives like Adobe become good enough, collapsing gross margins.
FV impact
-30%
Trigger
12-24 months
IAM Adoption Failure
High
Signaux d'alerte précoce à surveiller
Les cinq évolutions qui affaibliraient notre thèse d’investissement.
Successful expansion of Intelligent Agreement Management (IAM) accelerates revenue back to double-digits, while cost discipline drops the high incremental gross margins straight to the bottom line.
If IAM shows material billings acceleration, upside exists to mid-$30s. If core e-signature churns or pricing collapses, expect a re-rating into the low $20s.
Conforme
Hold
Déclencheur: In-line results
If IAM shows material billings acceleration, upside exists to mid-$30s. If core e-signature churns or pricing collapses, expect a re-rating into the low $20s.
Manqué
Reassess
Déclencheur: Downside surprise
If IAM shows material billings acceleration, upside exists to mid-$30s. If core e-signature churns or pricing collapses, expect a re-rating into the low $20s.
Qualité des résultats
If IAM shows material billings acceleration, upside exists to mid-$30s. If core e-signature churns or pricing collapses, expect a re-rating into the low $20s.
Actuel$622M non-cash SBC against $309M GAAP net income as of 2026-05-10
Pourquoi c'est important
Warning level: Stock-based compensation exceeds 20.0% of total revenue over any trailing twelve-month period. Excessive non-cash share issuance dilutes existing equity holders and prevents free cash flow generation from translating into GAAP per-share earnings growth.
Warning level: GAAP operating margin contracts year-over-year across any fiscal year. Operational margin contraction indicates a loss of operating leverage, where competitive price discounting and rising administrative overhead outpace software revenue expansion.
04
Métrique:
Annual Billings Growth Rate
Actuel8.2% revenue growth for the period ended 2026-01-31
Pourquoi c'est important
Warning level: Total billings growth falls below 0.0% across any trailing four-quarter window. Negative billings growth reflects severe forward bookings contraction as e-signature software commoditizes, leading inevitably to deferred revenue depletion and subsequent top-line revenue declines.
Warning level: Operating cash flow to net income drops below 1.000 over any trailing twelve-month period. Weakening operating cash generation relative to accounting profit points to uncollected enterprise receivables and unfavorable working capital movements, eliminating the primary cash flow support for valuation.
DOCU trades at 9.5x forward earnings against a peer median of 15.0x; EV/EBITDA of 25.5x against a peer median of 18.6x; 6 peers.
§10 Secteur et cycleEN
Phase du cycle
Expansion
Mature software companies pivot from aggressive growth investments to heavy cash return, attempting to outpace SBCdilution via share repurchases.
Cycle haussier
Enterprise digitization expands beyond simple signatures into full contract lifecycle management.
Cycle baissier
Software budget consolidation leads IT buyers to drop best-of-breed signature tools for bundled suite options.
Positionnement
Mature software companies pivot from aggressive growth investments to heavy cash return, attempting to outpace SBCdilution via share repurchases.
§11 Gestion de positionEN
Taille de position
Avoid. The synthesized fair value of $28.60 represents a material 52.5% discount to the street target.
Risque
Current holders should consider rotating out at current levels (~$47.90) as market pricing severely miscalculates the structural deceleration.
Tranches d'entrée
Niveau
Action
Pourquoi
Current / pullbacks
Requires a substantial pullback into the low $20s to provide a sufficient margin of safety against structural SBCdilution.
Requires a substantial pullback into the low $20s to provide a sufficient margin of safety against structural SBCdilution.
Tranches de sortie
Niveau
Action
Thesis break
Current holders should consider rotating out at current levels (~$47.90) as market pricing severely miscalculates the structural deceleration.
§12 Perspectives des investisseursEN
Bull view
Buy
Upside case depends on the report valuation range and named growth catalysts.
Base view
Sell
The private calibration street target of $60.16 anchors heavily on non-GAAP EPS that ignores the 19% of revenue paid in SBC.
§14 Recommandation finaleEN
Action
Vendre
DOCU is rated Sell at $47.90 versus the reconciled fair value midpoint of $28.60, implying -40.29% upside/downside.
At $47.90, the stock is measured against the final $28.60 midpoint and -40.29% upside/downside, so new capital should respect the report margin-of-safety discipline.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The Intelligent Agreement Management platform fails to gain traction among enterprise clients, limiting growth entirely to the saturated core e-signature market.
Operational margin contraction indicates a loss of operating leverage, where competitive price discounting and rising administrative overhead outpace software revenue expansion.
Actuel :9.3% for the period ended 2026-01-31
Alerte siGAAP operating margin contracts year-over-year across any fiscal year
04
Annual Billings Growth Rate
Negative billings growth reflects severe forward bookings contraction as e-signature software commoditizes, leading inevitably to deferred revenue depletion and subsequent top-line revenue declines.
Actuel :8.2% revenue growth for the period ended 2026-01-31
Alerte siTotal billings growth falls below 0.0% across any trailing four-quarter window
Weakening operating cash generation relative to accounting profit points to uncollected enterprise receivables and unfavorable working capital movements, eliminating the primary cash flow support for valuation.
DocuSign is a mature software compounder generating exceptional free cash flow and maintaining dominant market share in e-signature. However, heavy stock-based compensation and decelerating top-line growth present valuation headwinds. The base case assumes steady, low-growth cash generation with gradual GAAP margin improvement.
